Japan’s SoftBank Group Corp. is in early talks to invest close to $100 million in online medicine startup PharmEasy, three people aware of the matter said. PharmEasy is seeking a valuation of about $400 million in the latest round of funding, more than double what it was valued in the previous fundraising, the people cited above said on condition of anonymity.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com